Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study (Q28203542)

1

0 references

Peggy A Schuyler

2

0 references

Roy A Jensen

4

0 references

W Dale Plummer

5

0 references

Jean F Simpson

Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease

6

0 references

language of work or name

English

0 references

publication date

11 January 2003

0 references

published in

The Lancet

0 references

volume

361

0 references

issue

9352

0 references

page(s)

125-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

A prospective study of benign breast disease and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Lobular neoplasia. Long term risk of breast cancer and relation to other factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Lobular carcinoma in situ.Long term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Lobular carcinomain situ of the breast: Preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Prophylactic mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021

Total glandular mastectomy. Modifications of the subcutaneous mastectomy for use in premalignant disease of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912230-1

7 January 2021